Predictive models for major adverse cardiovascular events and myocardial injury or infarction improve with the addition of NT-proBNP or high-sensitivity cardiac troponin to the revised cardiac risk score in patients undergoing major non-cardiac surgery [24, 25]. The gene discussed is NPPB; the disease is infarction.